logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/04/2026
Elexus: The outlook for the North American market in 2026 has been revised from "neutral to negative" to "negative".
Latest
3 m ago
Each AI Express, Southwest Securities released a research report on April 24th, giving Chongqing Road and Bridge (600106.SH) a "hold" rating. The rating reasons mainly include: 1) the annual toll revenue from road and bridge tolls is fully collected, stabilizing the company's foundation for continuous operation and development; 2) the company's holdings in Yufu Expressway and Chongqing Bank have both contributed good investment returns; 3) the company actively seeks opportunities for development in advanced semiconductor and information industries. (Daily Economic News)
3 m ago
According to the AI flash news, Southwest Securities released a research report on April 24, giving Satellite Petrochemical (002648.SZ) a "buy" rating with a target price of 34.32 yuan. The rating reasons mainly include: 1) integrated advantages highlighted, high-end and overseas layout accelerating; 2) continuous progress of high value-added projects, significant effects of overseas expansion; 3) continuous optimization of business structure, differential performance of core sectors. (Daily Economic News)
3 m ago
Silver continuous main contract fell 4% intraday, now reported at 18500.00 yuan.
3 m ago
Each AI express news, Southwest Securities released a research report on Kang Chen Pharmaceutical (603590.SH) on April 24. The main points include: 1) The effectiveness of marketing capability building continues to show, and the market competitiveness of core products continues to improve continuously; 2) Focus on innovative research and development, continuously enriching the matrix of innovative varieties; 3) KC1086 has great market potential and successfully obtained the new drug clinical research permission from the US FDA. (Daily Economic News)
4 m ago
Din Tai Fung has incurred a loss of 1.5 billion yuan in the past five years, and its affiliated company was recently forced to pay a debt of 290,000 yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.